Chan Ho Cho

Nonarteritic anterior ischemic optic neuropathy after rapid weight loss during semaglutide therapy: a case report

Semaglutide, a glucagon-like peptide-1 receptor agonist, is increasingly used for obesity management; however, concerns have recently emerged regarding potential ocular adverse events, including nonarteritic anterior ischemic optic neuropathy (NAION). Herein, we report a case of...